Apollo Intelligent Driving Technology (beijing) Co., Ltd.

Betta Pharmaceuticals Co., Ltd.

Other

Baidu Online Network Technology (beijing) Co., Ltd.

Beta Pharma, Inc.

Beijing Betta Pharmaceuticals Co., Ltd

Beijing Baidu Netcom Science and Technology Co., Ltd.

Beijing Qihoo Technology Company Limited

Fujian Haixi Pharmaceuticals, Inc.

Betta Pharmacueticals Co., Ltd.

Kang, Xinshan

Yunyan Hu

Wei Long

Yinxiang Wang

Fenlai Tan

Yanping Wang

Cunbo Ma

Rui Liu

Ya Wang

Lieming Ding

Hong Cao

Yifeng Pan

Xinshan Kang

Lizhi Zhang

Qihao Huang

Wei He

Yong Liu

Ji Tao

Don Zhang

Shaojing Hu

Bin Han

Yaling Zhang

Guojian Xie

Xiaoyan Shen

Charles Davis

Xiangdong Zhao

Haima Ai

Hui Zhang

Wei Shan Dong

Lei Liu

Fei Wang

Yue Cui

Dayang Hao

Jing Yan

Simin Sui

Liufeng Zhou

Xiaojun Luo

Ruixiang Shen

Jianxi Zhang

Fanduo Kong

Yang Tao

Wentong Liu

Shujun Yuan

Haima Al

A vehicle performance evaluation method, device and terminal are provided. The method includes: acquiring a labeled ADE score of an ADE item within a time period in which the ADE item occurs, and recording labeled data of an ADE index for indicating a vehicle state; acquiring a correlation between the ADE item and the vehicle state, according to the labeled ADE score and the labeled data of the ADE index; acquiring data of a target ADE index within a preset time period, and acquiring a target ADE score according to the data of the target ADE index and a correlation between the ADE item and the vehicle state; and acquiring a vehicle performance evaluation result according to the target ADE score. The passenger participation is not necessary, costs can be reduced and a vehicle evaluation efficiency can be improved.

Vehicle performance evaluation method, device and terminal

Illustrative embodiments of the disclosure provide a method and apparatus for assessing a comfort level of a driving system. A method for generating an assessment model for comfort level in a driving system comprises acquiring a first assessment from a user on a comfort level of at least one traveling operation of the driving system, and acquiring a measurement of a traveling indicator of the driving system when performing the at least one traveling operation. The method further comprises generating the assessment model for the comfort level in the driving system based on the first assessment, the measurement of the traveling indicator, and a second assessment from the user on an overall comfort level of the driving system.

Method and apparatus for assessing comfort level of driving system

A method for detecting safety of a driving behavior, an apparatus, a device and a storage medium are provided. The method includes acquiring current driving data of a vehicle during a driving process of the vehicle; determining current driving behavior feature data of the vehicle according to the current driving data of the vehicle; inputting the current driving behavior feature data of the vehicle into a real-time safety detection model and calculating a security score corresponding to current driving behavior of the vehicle; and determining whether the current driving behavior of the vehicle is safe according to the security score corresponding to the current driving behavior of the vehicle. The method can assist an optimization of a vehicle driving system, reduce a safety risk of vehicle driving, and improve a riding experience of the user.

Method for detecting safety of driving behavior, apparatus, device and storage medium

Embodiments of the present disclosure disclose a method and apparatus for generating information. A specific embodiment of the method comprises: acquiring associated information of a road to be evaluated for driving difficulty; generating traffic environment information of the road based on the associated information; and inputting the traffic environment information of the road into a driving difficulty evaluation model to obtain a driving difficulty level of the road for an autonomous driving vehicle. The driving difficulty of the road for the autonomous driving vehicle is evaluated, to obtain the driving difficulty level of the road for the autonomous driving vehicle. Thus, based on a driving difficulty level of each road for the autonomous driving vehicle, the autonomous driving vehicle may select a road having a low driving difficulty level to drive.

Method and apparatus for generating information

Embodiments of the present invention provide a method and a system for sharing an application, and an application service platform. The method comprises: an application service platform, according to an application-sharing request sent from a source client, generates an application-sharing link containing an identifier of the source client, and returns the application-sharing link to the source client; the source client shares the sharing link with the target client; the application service platform, after receiving the connection request to the sharing link sent by the target client, generates an application installation package carrying the identifier of the source client, and returns the application installation package to the target client; the target client installs the application according to the installation package; an application service platform, after receiving an application login request sent by the target client, builds a friend-relationship between a user of the source client and a user of the target client according to the identifier of the source client carried in the application login request. The present invention, by means of application sharing, is able to facilitate establishment of a friend-relationship, enhances application interaction, and improves user experience.

Method and system for sharing application, and application service platform

The present invention relates to novel analogs of glucagon like peptide and compositions that are useful for up-regulating insulin expression in mammals and for treating diabetes. In particular, these peptide derivatives have a peptide mimic linker and provides long duration of action for the treatment of diabetes and other insulinotropic peptide related diseases, gastrointestinal function and activities associated with glucagon levels.

Glucagon like peptide analogs, composition, and method of use

The compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complexes thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity and related disorders. 

Compound for increasing kinase active and application thereof

The invention relates to 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, its therapeutic usage for treatment of diseases mediated by EGFR kinase and its combinatory therapeutic usage together with other therapeutic agents. The invention also provides synthetic methods for preparation of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride, its new crystalline forms, and the relevant synthetic intermediates for synthesis of 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-quinazoline hydrochloride.

Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof

The polymorphic forms of the compound of Formula I, the preparation thereof including the preparation of the intermediates, the pharmaceutical compositions thereof and the uses of a polymorph above in the manufacture of medicaments for treating a disease, a disorder or a condition are disclosed. 

Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof

The present invention relates to the polymorphic forms of the compound of Formula (I), preparation thereof including the preparation of intermediates and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder or a condition, or in the manufacturing of a medicament for the treatment of a disease, a disorder or a condition. 

Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof

Provided is a glucagon-like peptide-1 (GLP-1) analog shown as the following formula, wherein X is selected from glycine and glycinamide. The GLP-1 analog has a non-proteogenic amino acid residue in position 8 relative to the sequence GLP-1, and is acylated with a moiety comprising two acidic groups to the lysine residue in position 26. The GLP-1 analog is resistant to dipeptidyl peptidase IV so as to have an extended half-life in vivo. Also provided is a use of the GLP-1 analog in conquering blood sugar. 

Glucagon-like peptide-1 analogues and uses thereof

This invention relates to new compounds that can serve as hypoxia mimetics. This invention also relates to methods of increasing HIF levels or activity in a subject or treating a condition associated with HIF levels or activity in a subject by administering to the subject at least one of these compounds.

Compounds as hypoxia mimetics, and compositions and uses thereof

Growing community of inventors

Beijing, China

Yunyan Hu